ZBTB2 links p53 deficiency to HIF-1-mediated hypoxia signaling to promote cancer aggressiveness
Aberrant activation of the hypoxia-inducible transcription factor HIF-1 and dysfunction of the tumor suppressor p53 have been reported to induce malignant phenotypes and therapy resistance of cancers. However, their mechanistic and functional relationship remains largely unknown. Here, we reveal a m...
Prif Awduron: | Koyasu, S, Horita, S, Saito, K, Kobayashi, M, Ishikita, H, Chow, CC, Kambe, G, Nishikawa, S, Menju, T, Morinibu, A, Okochi, Y, Tabuchi, Y, Onodera, Y, Takeda, N, Date, H, Semenza, GL, Hammond, EM, Harada, H |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
EMBO Press
2022
|
Eitemau Tebyg
-
ZBTB7A forms a heterodimer with ZBTB2 and inhibits ZBTB2 homodimerization required for full activation of HIF-1
gan: Kambe, G, et al.
Cyhoeddwyd: (2024) -
UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization
gan: Nakashima, R, et al.
Cyhoeddwyd: (2017) -
UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization
gan: Ryota Nakashima, et al.
Cyhoeddwyd: (2017-07-01) -
LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis
gan: Yeom, CJ, et al.
Cyhoeddwyd: (2016) -
ZBTB1 is a determinant of lymphoid development.
gan: Siggs, O, et al.
Cyhoeddwyd: (2012)